Form ARS Aptevo Therapeutics Inc. For: Dec 31
Tweet
Share
E-mailATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ipsen appoints Mariette Finet to its Board of Directors
- RESUBMISSION: Allied Critical Metals Strengthens Borralha Project with Broad Tungsten Intercepts at Santa Helena Breccia, Including 15.8 Metres at 0.36% WO3 and 25.6 Metres at 0.25% WO3
- LEO Pharma Announces FDA Acceptance of Dersimelagon NDA with Priority Review and Closes Acquisition from Tanabe Pharma
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
